Publications for Wilbert S. Aronow wilbert_aronow@nymc.edu

NYMC School of Medicine
  • Revelo, A. E., Magaspi, C., Maguire, G., & Aronow, W. S. (2016). Hereditary amyloidosis with recurrent lung infiltrates. The American Journal of Case Reports, 17, 874-879. doi:10.12659/AJCR.900682

  • Rosendorff, C., Lackland, D. T., Allison, M., Aronow, W. S., Black, H. R., Blumenthal, R. S., . . . White, W. B. (2016). Treatment of hypertension in patients with coronary artery disease. A case-based summary of the 2015 AHA/ACC/ASH Scientific Statement. American Journal of Medicine, 129(4), 372-378. doi:10.1016/j.amjmed.2015.10.045

  • Saad, M., Nairooz, R., & Aronow, W. S. (2016). Letter by Saad et al. regarding article, "Outcomes with intravascular ultrasound-guided stent implantation: A meta-analysis of randomized trials in the era of drug-eluting stents". Circulation. Cardiovascular Interventions, 9(8), e003892. doi:10.1161/CIRCINTERVENTIONS.116.003892

  • Sanaani, A., Aronow, W. S., Paudel, R., & Cooper, H. (2016). Correlation between electrocardiographic changes and coronary angiography findings in patients with acute myocardial infarction and single-vessel disease. Cardiology, 134(Suppl 1), 343.

  • Sanam, K., Bhatia, V., Bajaj, N. S., Gaba, S., Morgan, C. J., Fonarow, G. C., . . . Aronow, W. S. (2016). Renin-angiotensin system inhibition and lower 30-day all-cause readmission in Medicare beneficiaries with heart failure. The American Journal of Medicine, 129(10), 1067-1073. doi:10.1016/j.amjmed.2016.05.008

  • Sen, P., Kundu, A., Sardar, P., Chatterjee, S., Nairooz, R., Amin, H., & Aronow, W. S. (2016). Outcomes after cardioversion in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants (NOACs): Insights from a meta-analysis. American Journal of Cardiovascular Drugs, 16(1), 33-41. doi:10.1007/s40256-015-0136-1

  • Serban, M. C., Sahebkar, A., Muntner, P., Howard, G., Ahmed, A., Graham, I., . . . Aronow, W. (2016). The effect of quercetin on blood pressure: A systematic review and meta-analysis of randomized controlled trials. Journal of the American College of Cardiology, 67(13), 2003. doi:10.1016/S0735-1097(16)32004-6

  • Serban, M. C., Sahebkar, A., Zanchetti, A., Mikhailidis, D. P., Howard, G., Aronow, W. S., . . . Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group. (2016). Effects of quercetin on blood pressure: A systematic review and meta-analysis of randomized controlled trials. Journal of the American Heart Association, 5(7), e002713. doi:10.1161/JAHA.115.002713

  • Sheriff, H., Lam, P. H., Arundel, C., Dooley, D. J., Panjrath, G., Fletcher, R. D., . . . Aronow, W.S., (2016). Discharge hospice referral is associated with lower 30-day all-cause readmission in hospitalized patients with heart failure: a propensity-matched study of the medicare-linked OPTIMIZE-HF. Circulation, 134(Suppl 1), A20782. This material can be found here.

  • Sheriff, H. M., Thogaripally, M., Arundel, C., Zeng, Q., Blackman, M., Aronow, W. S., & Ahmed, A. (2016). Digoxin and 30-day all-cause readmissions for nursing home residents hospitalized for heart failure. Gerontologist, 56(Suppl 3), 149. doi:10.1093/geront/gnw162.592

  • Sule, S.., Palaniswamy, C., Aronow, W. S., Adapa, S., Khera, S., Balasubramaniyam, N., . . . Nabors, C. (2016). Etiology of syncope in patients hospitalized with syncope and predictors of mortality and readmission for syncope at 17-month follow-up: A prospective study. American Journal of Therapeutics, 23(1), e2-e6. doi:10.1097/MJT.0b013e3182459957

  • Tomer, M. M., Gannuscio, J., Valentova, M., Fonarow, G., Adamopoulos, C., Kanonidis, I., . . . Aronow, W. (2016). Duration of heart failure and outcomes in patients with heart failure and reduced ejection fraction. European Journal of Heart Failure, 18(Suppl 1), 196-197.

  • Tommi, G., Aronow, W. S., Sheehan, J. C., McCleay, M. T., & Meyers, P. G. (2016). Comparison of efficacy and tolerance of automatic continuous positive airway pressure devices with the optimum continuous positive airway pressure. American Journal of Therapeutics, 23(6), e1532-e1536. doi:10.1097/MJT.0000000000000168

  • Tsimploulis, A., Lam, P. H., Dooley, D., Weerakoon, S., Arundel, C., Fletcher, R. D., . . . Aronow W. S. (2016). Lower discharge systolic blood pressure (SBP) and poor outcomes among hospitalized patients with heart failure and preserved ejection fraction (HFpEF) and stable admission-to-discharge SBP. Circulation, 134(Suppl 1), A20566. This material can be found here.

  • Tsimploulis, A., Weerakoon, S., Valentova, M., Morgan, C., Blackman, M. R., Butler, J., . . . Aronow, W. S. (2016). Baseline hypokalemia and long-term outcomes in ambulatory patients with heart failure with reduced ejection fraction (HFrEF) and New York Heart Association Class III-IV: a propensity-matched study of Beta-blocker valuation of Survival Trial (BEST). Journal of Cardiac Failure, 22(Suppl 8), S87. doi:10.1016/j.cardfail.2016.06.278

  • Valentova, M., Morgan, C. J., Butler, J., Blackman, M. R., Fonarow, G. C., Deedwania, P., . . . Aronow, W. S.  (2016). Hypokalemia and long-term outcomes in patients hospitalized for heart failure: A propensity-matched study. European Journal of Heart Failure, 18(Suppl 1), 263-264.

  • Valerio, M. G., Velayati, A., Jain, D., & Aronow, W. S. (2016). Promising new therapies for the treatment of hypercholesterolemia. Expert Opinion on Biological Therapy, 16(5), 609-618. doi:10.1517/14712598.2016.1148136

  • Velayati, A., Valerio, M. G., Shen, M., Tariq, S., Lanier, G. M., & Aronow, W. S. (2016). Update on pulmonary arterial hypertension pharmacotherapy. Postgraduate Medicine, 128(5), 460-473. doi:10.1080/00325481.2016.1188664

  • Vinson, L. D., Hemmy Asamsama, O., Arundel, C., Blackman, M., Aronow, W., Allman, R. M., & Ahmed, A. (2016). Are nursing home residents hospitalized for heart failure at higher risk for 30-day readmission? Gerontologist, 56(Suppl 3), 552. doi:10.1093/geront/gnw162.2222

  • Weerakoon, S., Tsimploulis, A., Arundel, C., Blackman, M., Morgan, C., Butler, J., . . . Aronow, W.S. (2016). Clinical effectiveness of digoxin in hospitalized older patients with heart failure and preserved ejection fraction: A propensity-matched study of medicare-linked OPTIMIZE-HF. Circulation, 134(Suppl 1), A20752. This material can be found here.

  • Yandrapalli, S., Aronow, W. S., Gass, A. L., Aggarwal, C., Frishman, W. H., Panza, J. A., . . . Lanier, G. M. (2016). Trends in sepsis and in-hospital mortality among heart transplant patients: A United States National Study. Circulation, 134(Suppl 1), A20503. This material can be found here.

  • Yoon, J., Gruboy, I. P., Zaid, A., Salil, S. G., Connolly, M., Aronow, W. S., . . . Zuberi, J. (2016). Isolated idiopathic aortitis with an unusually thickened aortic wall: Case report. Annals of Translational Medicine, 4(21), 428. doi:10.21037/atm.2016.11.14

  • Young, R. K., Goodlin, S., Wu, W. C., Morgan, C., Zhang, S., Bearden, D., . . . Aronow, W. S. (2016). Chronic opioid use is associated with significant higher 12-month all-cause readmission and all-cause mortality but not associated with 30-day all-cause readmission or all-cause mortality in older medicare beneficiaries hospitalized for heart failure. Journal of the American College of Cardiology, 67(13), 1428. This material can be found here.

  • Abdelmawgoud, A., Brown, C. J., Sui, X., Fonarow, G. C., Kokkinos, P. F., Bittner V, . . . Aronow, W. S. (2015). Relationship of physical activity and healthy eating with mortality and incident heart failure among community-dwelling older adults with normal body mass index. ESC Heart Failure, 2(1), 20-24. doi:10.1002/ehf2.12028

  • Ahmed, A. A., Patel, K., Nyaku, M. A., Kheirbek, R. E., Bittner, V., Mujib, M., Aronow, W. S.(2015). Risk of heart failure and death after prolonged smoking cessation: Role of amount and duration of prior smoking. Circulation. Heart Failure, 8(4), 694-701. doi:10.1161/CIRCHEARTFAILURE.114.001885

First Prev 1 2 3 4 5 6 7 8 9 10 Next Last